Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.34 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.33 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | CES1 | P23141 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3482527 | 0.85 | ACHE (0.43) | ESR1ESR2TDP1NR1H2NR1H3 | |
| SCHEMBL15641905 | 0.77 | ESR1 (0.46) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL7871195 | 0.75 | ESR1 (0.39) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL11904130 | 0.75 | ESR1 (0.39) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL273507 | 0.73 | ESR1 (0.42) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL49494 | 0.73 | ESR1 (0.42) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL49883 | 0.73 | ESR1 (0.42) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL6143069 | 0.73 | ESR1 (0.36) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL27957204 | 0.73 | ESR1 (0.42) | ESR1ESR2CA4CA14CA12 | |
| SCHEMBL709944 | 0.71 | ESR1 (0.40) | ESR1ESR2CA4CA14CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312494-B2 | Resin composition, method for producing same, and multi-liquid curable resin composition | KANEKA CORPORATION (JP) | 2025-05-27 | — | — | US | claimed |
| CN-119613965-A | Low-density flame-retardant organic silicon foam composition, silicone rubber foam material and preparation method thereof | 中蓝晨光化工研究设计院有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119286130-A | Flame-retardant polypropylene composition for automotive interiors and preparation method thereof | 重庆宝篆新材料科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-115003759-B | Resin composition, method for producing same, and multicomponent curable resin composition | 株式会社钟化 | 2023-12-01 | — | — | CN | claimed |
| CN-116082637-B | Thermosetting polyimide foam material based on 2, 3',4' -biphenyl tetracarboxylic dianhydride and preparation method thereof | 富优特(山东)新材料科技有限公司 | 2023-07-28 | — | — | CN | claimed |
| CN-116082637-A | Thermosetting polyimide foam material based on 2, 3',4' -biphenyl tetracarboxylic dianhydride and preparation method thereof | 富优特(山东)新材料科技有限公司 | 2023-05-09 | — | — | CN | claimed |
| US-20220340777-A1 | RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MULTI-LIQUID CURABLE RESIN COMPOSITION | KANEKA CORPORATION (JP) | 2022-10-27 | — | — | US | claimed |
| CN-115003759-A | Resin composition, method for producing same, and multi-component curable resin composition | 株式会社钟化 | 2022-09-02 | — | — | CN | claimed |
| US-20190203088-A1 | Adhesion-Imparting Agent and Curable Resin Composition | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2019-07-04 | — | — | US | claimed |
| EP-3453735-A1 | ADHESION-IMPARTING AGENT AND CURABLE RESIN COMPOSITION | The Yokohama Rubber Co., Ltd. (JP) | 2019-03-13 | — | — | EP | claimed |
| US-8865926-B2 | Process for the production of cyclosiloxanes | SIVANCE, LLC (US) | 2014-10-21 | — | — | US | claimed |
| EP-2760873-A1 | PROCESS FOR THE PRODUCTION OF CYCLOSILOXANES | Milliken & Company (US) | 2014-08-06 | — | — | EP | claimed |
| WO-2013048938-A1 | PROCESS FOR THE PRODUCTION OF CYCLOSILOXANES | MILLIKEN & COMPANY (US) | 2013-04-04 | — | — | WO | claimed |
| US-20130079539-A1 | PROCESS FOR THE PRODUCTION OF CYCLOSILOXANES | SIVANCE LLC (US) | 2013-03-28 | — | — | US | claimed |
| EP-1939686-B1 | Holographic recording medium | TOSHIBA KK (JP) | 2010-11-17 | — | — | EP | claimed |
| US-7705346-B2 | Barrier layer for an organic electronic device | XEROX CORPORATION (US) | 2010-04-27 | — | — | US | claimed |
| US-20060273302-A1 | Barrier layer for an organic electronic device | XEROX CORPORATION | 2006-12-07 | — | — | US | claimed |
| US-20060171870-A1 | PROCESS OF MAKING HYDROPHOBIC METAL OXIDE NANOPARTICLES | XEROX CORPORATION (US) | 2006-08-03 | — | — | US | claimed |
| US-7081234-B1 | Mixing metal oxide nanoparticles, a solvent, and a surface treatment agent, heating | XEROX CORPORATION (US) | 2006-07-25 | — | — | US | claimed |
| US-20050233231-A1 | Photoconductive imaging members | XEROX CORPORATION | 2005-10-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079539-A1 | PROCESS FOR THE PRODUCTION OF CYCLOSILOXANES | ESD, PCNA, MCM5 | ESR1 2910/4885ESR2 4153/4885CA4 354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.